AZIYO BIOLOGICS INC - CLASS A
AZIYO BIOLOGICS INC - CLASS A
Share · US05479K1060 · AZYO (XNAS)
Overview Financial Indicators
1,95 USD
3,72 % 0,07 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
10.06.2025 18:00

Current Prices from AZIYO BIOLOGICS INC - CLASS A

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
ELUT
USD
10.06.2025 18:00
1,95 USD
1,88 USD
+3,72 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
3,72 % 2,09 % -3,23 % -31,34 % -53,24 % -42,82 % -86,55 %

Company Profile for AZIYO BIOLOGICS INC - CLASS A Share

Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

Company Data

Name AZIYO BIOLOGICS INC - CLASS A
Company Aziyo Biologics, Inc.
Symbol AZYO
Website https://www.aziyo.com
Primary Exchange XNAS NASDAQ
ISIN US05479K1060
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Dr. C. Randal Mills Ph.D.
Market Capitalization 24 Mio
Country United States of America
Currency USD
Employees 0,2 T
Address 12510 Prosperity Drive, 20904 Silver Spring
IPO Date 2020-10-08

ID Changes

Date From To
07.09.2023 AZYO ELUT

Ticker Symbols

Name Symbol
NASDAQ AZYO
NASDAQ ELUT

More Shares

Investors who AZIYO BIOLOGICS INC - CLASS A hold also have the following shares in their portfolio:
AFR. DEV. BK 17/22 MTN
AFR. DEV. BK 17/22 MTN Bond
TREASURY STK 2029 INF.LIN
TREASURY STK 2029 INF.LIN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025